ACAD - ACADIA Pharmaceuticals Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 52.71B
Enterprise Value 32.06B
Trailing P/E N/A
Forward P/E 1-10.70
PEG Ratio (5 yr expected) 1-0.68
Price/Sales (ttm)13.02
Price/Book (mrq)10.54
Enterprise Value/Revenue 39.93
Enterprise Value/EBITDA 6-8.35

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Sep 30, 2018


Profit Margin -119.62%
Operating Margin (ttm)-120.39%

Management Effectiveness

Return on Assets (ttm)-45.98%
Return on Equity (ttm)-82.75%

Income Statement

Revenue (ttm)207.8M
Revenue Per Share (ttm)1.67
Quarterly Revenue Growth (yoy)63.90%
Gross Profit (ttm)-37.35M
EBITDA -247.25M
Net Income Avi to Common (ttm)-248.57M
Diluted EPS (ttm)-1.99
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)214.14M
Total Cash Per Share (mrq)1.71
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)6.08
Book Value Per Share (mrq)1.79

Cash Flow Statement

Operating Cash Flow (ttm)-158.39M
Levered Free Cash Flow (ttm)-70.81M

Trading Information

Stock Price History

Beta (3Y Monthly) 3.88
52-Week Change 3-36.36%
S&P500 52-Week Change 3-1.03%
52 Week High 332.99
52 Week Low 312.77
50-Day Moving Average 319.66
200-Day Moving Average 317.58

Share Statistics

Avg Vol (3 month) 33M
Avg Vol (10 day) 31.55M
Shares Outstanding 5143.63M
Float 90.09M
% Held by Insiders 128.37%
% Held by Institutions 187.01%
Shares Short (Nov 15, 2018) 416.06M
Short Ratio (Nov 15, 2018) 45.51
Short % of Float (Nov 15, 2018) 420.39%
Short % of Shares Outstanding (Nov 15, 2018) 412.84%
Shares Short (prior month Oct 15, 2018) 418.44M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A